Conjupri
NDC 24075-0413, levamlodipine, tablet, from CSPC Ouyi Pharmaceutical Co. Ltd.
- Product NDC
- 24075-0413
- Status
- Listed
- Labeler
- CSPC Ouyi Pharmaceutical Co. Ltd
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA212895
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/24075-0413 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LEVAMLODIPINE MALEATE5 mg/5mg
| Package NDC | NDC-11 | Package |
|---|---|---|
| 24075-0413-3 | 24075041303 | 5 mg in 1 BOTTLE (24075-0413-3) |
| 24075-0413-5 | 24075041305 | 5 mg in 1 BOTTLE (24075-0413-5) |
| 24075-0413-9 | 24075041309 | 5 mg in 1 BOTTLE (24075-0413-9) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c3cca66e-348a-43e8-8f96-e995104dae3d
Use it
Look up 24075-0413 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/24075-0413 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 24075-0413. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.